Bone and Joint Diseases
Bone and Joint Diseases is a research topic within Orthopedics and Sports Medicine. Science Explorer counts 28k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the pathogenesis, natural history, and treatment of osteonecrosis, particularly in the femoral head. It covers topics such as the use of stem cell therapy, core decompression, glucocorticoid-induced osteonecrosis, and the role of bone marrow in the development and diagnosis of osteonecrosis. MRI imaging is also explored for its insights into the condition.
- Osteonecrosis
- Femoral Head
- Bone Marrow
- Treatment
- Pathophysiology
- MRI Imaging
- Core Decompression
- Stem Cell Therapy
- Glucocorticoid-induced
- Avascular Necrosis
- Research works
- 28k fractional, since 1950
- In the world top 10%
- 2.8k per year above
- Top-10% rate
- 10.0% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +1% the tick is no change
- Largest producer
China
29% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Bone and Joint Diseases research?
By volume, China and the United States publish the most (1.1k and 971 works in 2022-now).
By volume, 2022-now
- 1
China 1.1k works
- 2
United States 971 works
- 3
Japan 318 works
- 4
India 300 works
- 5
Germany 192 works
- 6
United Kingdom 191 works
- 7
Türkiye 168 works
- 8
South Korea 160 works
- 9
Italy 159 works
- 10
France 137 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Bone and Joint Diseases research?
By volume in 2022-now, Harvard University publishes the most Bone and Joint Diseases research, followed by Peking University and Shanghai Jiao Tong University.
By volume, 2022-now
- 1
Harvard University
United States 39 works
- 2
Peking University
China 38 works
- 3
Shanghai Jiao Tong University
China 34 works
- 4
All India Institute of Medical Sciences
India 30 works
- 5
Sichuan University
China 29 works
- 6
Mayo Clinic
United States 24 works
- 7
Sun Yat-sen University
China 23 works
- 8
Nanjing Medical University
China 20 works
- 9
Seoul National University
South Korea 19 works
- 10
Guangzhou University of Chinese Medicine
China 19 works
Who are the leading researchers in Bone and Joint Diseases?
The most-cited researchers publishing on Bone and Joint Diseases include David Moher, George Davey Smith and Cyrus Cooper.
- 1
David Moher
Canada 898k citations
- 2
George Davey Smith
United Kingdom 435k citations
- 3
Cyrus Cooper
United Kingdom 342k citations
- 4
Matthias Egger
Switzerland 326k citations
- 5
Gordon Henry Guyatt
Canada 315k citations
- 6
Peter Jüni
Switzerland 303k citations
- 7
Luigi Ferrucci
United States 281k citations
- 8
Hagop M. Kantarjian
United States 273k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Bone and Joint Diseases research done?
The largest centres of Bone and Joint Diseases research in 2022-now are Beijing (China), Shanghai (China), Seoul (South Korea) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Shijiazhuang.
Largest cities, 2022-now
Where it is the local speciality
- ShijiazhuangCN · 22.8 works4.4×
Location quotient: how much more of its research is in Bone and Joint Diseases than the world average.
Where is the best place to study Bone and Joint Diseases?
Among universities, judged by research, Wenzhou Medical University, Harvard University and Shanghai Jiao Tong University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Bone and Joint Diseases, country by countryIs Bone and Joint Diseases research growing?
Output in 2022-2025 was 1% higher than in 2018-2021, peaking in 2020. The fastest-growing topics are Bone and Joint Diseases.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Bone and Joint Diseases as a percentage of every work published that year, 0.021% in 2024.
Fractional works of Bone and Joint Diseases over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Bone and Joint Diseases. Posts are plain text and can be reported.